Search
Zoliflodacin
go.drugbank.com/drugs/DB12817ApprovedInvestigational[A274938,L54748] It is indicated as a single-dose oral therapy for the treatment of uncomplicated urogenital gonorrhea.
Obecabtagene autoleucel
go.drugbank.com/drugs/DB17362ApprovedInvestigational[A265040,A265045] It works by targeting B-cell-specific CD19 surface markers present on malignant B cells. … [L52450] Obecabtagene autoleucel was also investigated in other hematological cancers and systemic lupus erythematosus.[A265045]
Categories: Genetically-modified Autologous T Cells, CD19-Directed Genetically Modified Autologous T-cell ImmunotherapiesSynonyms: AUTOLOGOUS CD4+ AND CD8+ T CELLS, ENRICHED FROM PERIPHERAL BLOOD MONONUCLEAR CELLS (PBMCS) OBTAINED BY APHERESIS TRANSDUCED EX VIVO WITH A NON-REPLICATING, SELF-INACTIVATING (SIN) LENTIVIRAL VECTOR, ENCODINGTrilaciclib
go.drugbank.com/drugs/DB15442ApprovedInvestigational[A229323] Trilaciclib was first described in the literature in 2016.[A229313] Trilaciclib was granted FDA approval on 12 February 2021.[L31823]
Atractylodes lancea root oil
go.drugbank.com/drugs/DB14338ApprovedIt is not an approved drug.
Mixtures: OHUI Sun Science Sun Block EX plus BeigePirbuterol
go.drugbank.com/drugs/DB01291ApprovedWithdrawnThe precise function of these receptors has not been established. … In vitro studies and in vivo pharmacologic studies have demonstrated that pirbuterol has a preferential effect on beta-2 Adrenergic receptors compared with isoproterenol.
Polythiazide
go.drugbank.com/drugs/DB01324Approved(From Martindale, The Extra Pharmacopoeia, 30th ed, p826)
Phenacetin
go.drugbank.com/drugs/DB03783ApprovedWithdrawnPhenacetin was withdrawn from the Canadian market in June 1973 due to concerns regarding nephropathy (damage to or disease of the kidney).
Liotrix
go.drugbank.com/drugs/DB01583ApprovedLiotrix was developed when it was believed that serum levels of both T4 and T3 were maintained by direct thyroidal secretion. … It consists of levothyroxine sodium (thyroxine, T4) and liothyronine sodium (triiodothyronine, T3) in a 4 to 1 ratio by weight.
Icaridin
go.drugbank.com/drugs/DB14074InvestigationalIcaridin has been commonly used as a topically-applied insect repellent in various countries but was officially licensed for use in the United States in 2001 and Canada in 2012 [L4595]. … It is considered to be the first choice of repellent by the Public Health Agency of Canada’s Canadian Advisory Committee on Tropical Medicine and Travel for travelers six months to 12 years of age [A39203